CTOs on the Move

Nitro Microsystems

www.nitro.ca

 
Nitro Microsystems Inc. is a Ottawa, ON-based company in the Business Services sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.nitro.ca
  • 1736 Courtwood Cres
    Ottawa, ON CAN K2C 2B5
  • Phone: 613.228.8096

Executives

Name Title Contact Details

Similar Companies

Image One PR Consulting

Image One PR Consulting is a Rockville, MD-based company in the Business Services sector.

Mpdc

Mpdc is a Miramichi, NB-based company in the Business Services sector.

Pro Specialties Group Inc

Pro Specialties Group Inc is a San Diego, CA-based company in the Business Services sector.

American School for the Deaf

The American School for the Deaf (ASD), established in 1817 in Hartford, Connecticut, is the oldest permanent school for the deaf in the United States. Founded by Thomas Hopkins Gallaudet, Mason Cogswell, and Laurent Clerc, ASD was created to provide education and communication skills to deaf children, addressing the need for local educational facilities at the time. The school has played a significant role in the development of Deaf culture and education in America. ASD offers comprehensive educational services for deaf and hard-of-hearing students, functioning as both a residential and day school. It provides a full academic curriculum along with specialized instruction in American Sign Language (ASL) and Deaf culture. The school promotes a community environment that supports the language, social, and academic development of its students. Additionally, ASD maintains extensive archives related to deaf education and culture, serving as valuable resources for scholars and the Deaf community.

Galapagos

We are a biotechnology company with operations in Europe and the U.S. dedicated to developing transformational medicines for more years of life and quality of life. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies, and biologics in oncology and immunology. With capabilities from lab to patient, including a decentralized, point-of-care CAR-T manufacturing network, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.